0001209191-21-013504.txt : 20210223
0001209191-21-013504.hdr.sgml : 20210223
20210223201209
ACCESSION NUMBER: 0001209191-21-013504
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210219
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kruteck Michael C.
CENTRAL INDEX KEY: 0001800864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38594
FILM NUMBER: 21668007
MAIL ADDRESS:
STREET 1: 2701 EASTLAKE AVE E
STREET 2: 3RD FLOOR
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 MAUGHAN ROAD
CITY: NANAIMO
STATE: A1
ZIP: V9X 1J2
BUSINESS PHONE: 2064329325
MAIL ADDRESS:
STREET 1: 1100 MAUGHAN ROAD
CITY: NANAIMO
STATE: A1
ZIP: V9X 1J2
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-19
0
0001731348
Tilray, Inc.
TLRY
0001800864
Kruteck Michael C.
2701 EASTLAKE AVE E
3RD FLOOR
SEATTLE
WA
98102
0
1
0
0
Chief Financial Officer
Class 2 Common Stock
2021-02-19
4
A
0
53191
0.00
A
53191
D
Class 2 Common Stock
2021-02-19
4
F
0
23476
0.00
D
29715
D
Restricted Stock Units
2021-02-19
4
A
0
53192
0.00
A
Class 2 Common Stock
53192
53192
D
On August 5, 2020, the Reporting Person was granted restricted stock units ("RSU"), which represented a contingent right to receive 106,383 shares of the Issuer's Class 2 Common Stock. The RSU was to vest 50% upon the filing date of the Issuer's Annual Report on Form 10-K for the year ended December 31, 2020, provided that the Issuer achieved certain performance criteria for fourth quarter 2020 (the "Performance Criteria"). The Performance Criteria was met on February 19, 2021, resulting in the vesting of 53,191 shares under this RSU.
Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of the RSU.
Each RSU represents a contingent right to receive one share of the Issuer's Class 2 Common Stock.
On February 19, 2021 the Performance Criteria was met allowing for the remaining 50% of the RSU (53,192 shares) to vest on January 1, 2022, subject to the Reporting Person providing continuous service to the Issuer until such date.
/s/ Julia Stark, Attorney-in-fact
2021-02-23